Consider the following medical report that includes the patient's historical health records. Use it to predict the disease that the patient is high likely exposed to. 

 Medical Report: allergies: darvon / penicillins attending: chief complaint: chest pain major surgical or invasive procedure: coronary artery bypass graft x 5 (lima to lad, svg to diag, svg to om, svg to pda to plb) history of present illness: 65 y/o male with h/o hypertension and hypercholesterolemia who had increasing symptoms of exertional chest pressure. accompanied with shortness of breath. cardiac cath revealed in-stent stenosis of rca stent as well as three vessel disease. he continued to have chest pain post-cath and was transferred to for surgery. past medical history: coronary artery disease s/p pci/stent , hypertension, hypercholesterolemia, diverticulosis, lyme disease, osteoarthritis, retinal hemorrhage social history: former smoker, quit 18 yrs ago. 1 glass red wine/daily. married, lives with wife and works as a veterinarian. family history: positive for premature cad. physical exam: vs: 118/72 68 18 neck: supple, from, -jvd lungs: ctab cardiac: rrr +s1s2 abd: soft, nt/nd +bs ext: warm, well-perfused 2+ pulses throughout neuro: a&o x 3, mae, non-focal pertinent results: 10:20am blood wbc-5.9 rbc-2.84* hgb-9.3* hct-26.6* mcv-94 mch-32.9* mchc-35.1* rdw-13.4 plt ct-343 08:10pm blood wbc-5.3 rbc-4.15* hgb-13.6* hct-36.4* mcv-88 mch-32.7* mchc-37.3* rdw-12.9 plt ct-228 10:20am blood plt ct-343 08:10pm blood pt-12.8 ptt-28.8 inr(pt)-1.1 08:10pm blood plt ct-228 06:35am blood glucose-105 urean-24* creat-1.0 na-138 k-4.4 cl-103 hco3-29 angap-10 08:10pm blood glucose-90 urean-20 creat-0.9 na-139 k-3.9 cl-103 hco3-28 angap-12 08:10pm blood alt-25 ast-25 ld(ldh)-187 ck(cpk)-86 alkphos-44 totbili-0.5 08:10pm blood ck-mb-4 ctropnt-<0.01 03:30pm blood mg-2.5 08:10pm blood albumin-4.1 08:10pm blood %hba1c-5.7 chest (pa & lat) 10:36 am chest (pa & lat) reason: eval for pneumothoraces medical condition: 65 year old man s/p cabg reason for this examination: eval for pneumothoraces history: status post cabg, to evaluate for change in pneumothoraces. findings: in comparison with the study of , there is little change in the bilateral pneumothoraces, more marked on the right. bibasilar opacifications persist consistent with some combination of effusion and atelectasis. impression: little overall change. dr. approved: 11:01 am cardiology report ecg study date of 2:00:24 pm the first two beats are atrial paced. then there is a pause and sinus rhythm with p-r interval prolongation ensues. there is borderline low limb lead voltage. consider inferior wall myocardial infarction of indeterminate age. there is mild j point and st segment elevation in early precordial leads. compared to the previous tracing of the atrial pacing is new. limb lead voltage is diminished. read by: , a. intervals axes rate pr qrs qt/qtc p qrs t 64 228 88 404/411 53 -27 22 echocardiography report , (complete) done at 11:45:48 am final referring physician information , division of cardiothoracic , status: inpatient dob: age (years): 65 m hgt (in): bp (mm hg): / wgt (lb): hr (bpm): bsa (m2): indication: intraoperative tee for cabg icd-9 codes: 440.0, 424.0 test information date/time: at 11:45 interpret md: , md test type: tee (complete) son: , md doppler: full doppler and color doppler test location: anesthesia west or cardiac contrast: none tech quality: adequate tape #: 2008aw2-: machine: b- echocardiographic measurements results measurements normal range left ventricle - inferolateral thickness: 1.1 cm 0.6 - 1.1 cm left ventricle - diastolic dimension: 4.9 cm <= 5.6 cm left ventricle - ejection fraction: 55% to 60% >= 55% aorta - ascending: *3.8 cm <= 3.4 cm aorta - descending thoracic: *2.8 cm <= 2.5 cm findings left atrium: mild spontaneous echo contrast in the body of the la. all four pulmonary veins identified and enter the left atrium. right atrium/interatrial septum: lipomatous hypertrophy of the interatrial septum. no asd by 2d or color doppler. left ventricle: wall thickness and cavity dimensions were obtained from 2d images. normal lv wall thickness, cavity size, and systolic function (lvef>55%). right ventricle: rv not well seen. normal rv systolic function. aorta: focal calcifications in aortic root. mildly dilated ascending aorta. simple atheroma in ascending aorta. focal calcifications in ascending aorta. simple atheroma in aortic arch. simple atheroma in descending aorta. focal calcifications in descending aorta. aortic valve: mildly thickened aortic valve leaflets (3). no ar. mitral valve: mildly thickened mitral valve leaflets. mild mvp. physiologic mr (within normal limits). tricuspid valve: tricuspid valve not well visualized. tr present - cannot be quantified. pulmonic valve/pulmonary artery: pulmonic valve not well seen. physiologic (normal) pr. pericardium: trivial/physiologic pericardial effusion. general comments: a tee was performed in the location listed above. i certify i was present in compliance with hcfa regulations. the patient was under general anesthesia throughout the procedure. no tee related complications. the patient appears to be in sinus rhythm. results were personally reviewed with the md caring for the patient. conclusions pre cpb mild spontaneous echo contrast is seen in the body of the left atrium. no atrial septal defect is seen by 2d or color doppler. left ventricular wall thickness, cavity size, and systolic function are normal (lvef>55%). views of the right ventricle are limited but there appears to be normal free wall contractility. the ascending aorta is mildly dilated. there are simple atheroma in the ascending aorta. there are simple atheroma in the aortic arch. there are simple atheroma in the descending thoracic aorta. the aortic valve leaflets (3) are mildly thickened. no aortic regurgitation is seen. the mitral valve leaflets are mildly thickened. physiologic mitral regurgitation is seen (within normal limits). tricuspid regurgitation is present but cannot be quantified. there is a trivial/physiologic pericardial effusion. post cpb normal biventricular systolic function. no significant change from pre bypass. i certify that i was present for this procedure in compliance with hcfa regulations. electronically signed by , md, interpreting physician 12:59 brief hospital course: mr. was transferred to after his cardiac cath for surgical intervention. he was appropriately worked-up and was receiving medical management while waiting for plavix to washout. mr. continued to have chest pain though and required iv nitroglycerin gtt. therefore he was brought to the operating room earlier, , where he underwent a coronary artery bypass graft x 5. please see operative report for surgical details. following surgery he was transferred to the cvicu for invasive monitoring in stable condition. later on op day he was weaned from sedation, awoke neurologically intact and extubated. on post-op day one his chest tubes were removed and he was started on beta-blockers and diuretics. he was gently diuresed towards his pre-op weight. later on this day he was transferred to the telemetry floor further care. physical therapy worked with him for strength and mobility. he continued to progress and was ready for discharge home with vna services pod 4. medications on admission: plavix, aspirin, lipitor, lopressor, monopril, hctz, metamucil, nitro sl discharge medications: 1. docusate sodium 100 mg capsule sig: one (1) capsule po bid (2 times a day). disp:*60 capsule(s)* refills:*0* 2. aspirin 81 mg tablet, delayed release (e.c.) sig: one (1) tablet, delayed release (e.c.) po daily (daily). disp:*30 tablet, delayed release (e.c.)(s)* refills:*0* 3. atorvastatin 80 mg tablet sig: one (1) tablet po daily (daily). disp:*30 tablet(s)* refills:*0* 4. hydromorphone 2 mg tablet sig: 1-2 tablets po q4h (every 4 hours) as needed. disp:*50 tablet(s)* refills:*0* 5. metoprolol tartrate 50 mg tablet sig: one (1) tablet po tid (3 times a day). disp:*90 tablet(s)* refills:*0* 6. furosemide 20 mg tablet sig: one (1) tablet po once a day for 10 days. disp:*10 tablet(s)* refills:*0* 7. motrin 400 mg tablet sig: 1-2 tablets po every six (6) hours as needed for pain. disp:*30 tablet(s)* refills:*0* 8. potassium chloride 20 meq tab sust.rel. particle/crystal sig: one (1) tab sust.rel. particle/crystal po once a day for 10 days. disp:*10 tab sust.rel. particle/crystal(s)* refills:*0* 9. ranitidine hcl 150 mg tablet sig: one (1) tablet po once a day. disp:*30 tablet(s)* refills:*0* discharge disposition: home with service facility: discharge diagnosis: coronary artery disease s/p coronary artery bypass graft x 5 pmh: pci/stent , hypertension, hypercholesterolemia, diverticulosis, lyme disease, osteoarthritis, retinal hemorrhage discharge condition: good discharge instructions: please shower daily including washing incisions, no baths or swimming monitor wounds for infection - redness, drainage, or increased pain report any fever greater than 101 report any weight gain of greater than 2 pounds in 24 hours or 5 pounds in a week no creams, lotions, powders, or ointments to incisions no driving for approximately one month no lifting more than 10 pounds for 10 weeks please call with any questions or concerns p instructions: 6 in 2 weeks for wound check dr. in 4 weeks dr. in weeks (cardiologist) dr. in weeks (pcp) procedure: single internal mammary-coronary artery bypass extracorporeal circulation auxiliary to open heart surgery (aorto)coronary bypass of four or more coronary arteries continuous intra-arterial blood gas monitoring diagnoses: coronary atherosclerosis of native coronary artery pure hypercholesterolemia unspecified essential hypertension personal history of tobacco use other complications due to other cardiac device, implant, and graft 

Answer: The patient is high likely exposed to